Skip to content

The effect of repeated transcranial magnetic stimulation on post-stroke depression and the and mechanism research by functinal MRI

The development and application of multidimensional interventions on post-stroke depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024245
Enrollment
Unknown
Registered
2019-07-02
Start date
2019-06-21
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke depression

Interventions

depression one:transcranial magnetic stimulation
depression two:transcranial magnetic stimulation
control one:false stimulation
motor group:transcranial magnetic stimulation
control two:false stimulation

Sponsors

Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Previous history of subcortical stroke; (2) The onset time of stroke was 3 months to 1 year for non-acute stroke; (3) Aged 40 to 75 years; (4) HAMD (7-21 points), cesd-sc (> 20 points), FMA (50-95 points), Bs stage >=3, NIHSS < 12, conventional rehabilitation treatment; (5) Sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with acute stroke and cerebral trauma. (2) Intracranial infection, effusion or tumor occupation. (3) Intracranial metal and other foreign bodies (such as orthopedic materials, arterial clips, etc.). (4) The body has pacemaker, deep brain stimulator and other electronic equipment. (5) Previous seizures, including primary epilepsy and secondary epilepsy. (6) Severe complications after stroke, such as pneumonia and heart disease. (7) Previous history of depression and antidepressant use. (8) Cognitive dysfunction or aphasia (MMSE < 17). (9) Patients who cannot cooperate in neuropsychological testing; (10) Not following the prescribed treatment regimen and poor compliance.

Design outcomes

Primary

MeasureTime frame
HAMD-17;FMA;MMSE;HAM-A;Pittsburgh sleep scale;Brain MRI scan;

Secondary

MeasureTime frame
NIH Stroke Scale, NIHSS;Modified Rankin Scale;CESD-SC;

Countries

China

Contacts

Public ContactSuiqiang Zhu

Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

zhusuiqiang@163.com+86 13035101141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026